Christopher Cheng

Christopher Cheng

Company: Verve Therapeutics

Job title: VP - Process Development & RNA Technology


Seminar: mRNA Drug Substance Attributes & Manufacturing Considerations for Gene Editing Therapeutics

  • GMP manufacture of mRNA drug substance
  • mRNA process development and scale-up challenges
  • mRNA attributes and impurities that affect gene editing performance in non-human primate

Day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.